PIM
BPMC
Partner Investment Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-9,766
| Closed | -$782K | – | 80 |
|
|
2019
Q1 | $782K | Sell |
9,766
-6,166
| -39% | -$494K | 0.9% | 37 |
|
|
2018
Q4 | $859K | Buy |
15,932
+495
| +3% | +$26.7K | 1.07% | 31 |
|
|
2018
Q3 | $1.21M | Buy |
15,437
+5,648
| +58% | +$441K | 0.92% | 39 |
|
|
2018
Q2 | $621K | Sell |
9,789
-657
| -6% | -$41.7K | 0.5% | 66 |
|
|
2018
Q1 | $958K | Buy |
10,446
+426
| +4% | +$39.1K | 1.04% | 41 |
|
|
2017
Q4 | $756K | Sell |
10,020
-11,232
| -53% | -$847K | 0.87% | 42 |
|
|
2017
Q3 | $1.48M | Buy |
21,252
+2,630
| +14% | +$183K | 1.41% | 21 |
|
|
2017
Q2 | $944K | Buy |
18,622
+2,874
| +18% | +$146K | 1.27% | 27 |
|
|
2017
Q1 | $630K | Buy |
15,748
+5,113
| +48% | +$205K | 0.77% | 49 |
|
|
2016
Q4 | $298K | Buy |
10,635
+1,373
| +15% | +$38.5K | 0.39% | 63 |
|
|
2016
Q3 | $275K | Sell |
9,262
-10,787
| -54% | -$320K | 0.41% | 64 |
|
|
2016
Q2 | $406K | Buy |
20,049
+1,261
| +7% | +$25.5K | 0.66% | 40 |
|
|
2016
Q1 | $339K | Buy |
18,788
+736
| +4% | +$13.3K | 0.55% | 43 |
|
|
2015
Q4 | $475K | Buy |
18,052
+7,898
| +78% | +$208K | 0.78% | 42 |
|
|
2015
Q3 | $217K | Buy |
10,154
+2,804
| +38% | +$59.9K | 0.33% | 56 |
|
|
2015
Q2 | $195K | Buy |
+7,350
| New | +$195K | 0.27% | 68 |
|